First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 4.13 USD 8.68%
Updated: May 14, 2024

Adaptive Biotechnologies Corp
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adaptive Biotechnologies Corp
Accounts Receivables Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Accounts Receivables
$42m
CAGR 3-Years
29%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Accounts Receivables
$9.7B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
17%
Danaher Corp
NYSE:DHR
Accounts Receivables
$3.4B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Accounts Receivables
$650.3m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accounts Receivables
$1.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
4%
IQVIA Holdings Inc
NYSE:IQV
Accounts Receivables
$3.4B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
14%

See Also

What is Adaptive Biotechnologies Corp's Accounts Receivables?
Accounts Receivables
42m USD

Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Accounts Receivables amounts to 42m USD.

What is Adaptive Biotechnologies Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
59%

Over the last year, the Accounts Receivables growth was 36%. The average annual Accounts Receivables growth rates for Adaptive Biotechnologies Corp have been 29% over the past three years , 59% over the past five years .